Instrument Inactif

Communiqués Receptos Inc

Actions

US7562071065

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

15/07/15	Bank of America : Wall Street finit hésitante après les propos de Janet Yellen	RE
15/07/15	Wall Street finit hésitante après les propos de Yellen	RE

Communiqués

22/07/15	Receptos : Results of the Phase 2 TOUCHSTONE Trial - Report on Receptos, Inc.	PR
17/07/15	Receptos : Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases	PU
17/07/15	Receptos : Ryan & Maniskas, LLP : Investigation of Receptos, Inc.	PR
16/07/15	Receptos : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Receptos, Inc. Stockholders	BU
15/07/15	Receptos : Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
28/05/15	Receptos to Present at Jefferies 2015 Global Healthcare Conference	GL
15/05/15	Receptos Announces Oral Plenary Presentation of TOUCHSTONE Phase 2 Induction Data at Digestive Disease Week 2015	GL
14/05/15	Receptos to Present at UBS Global Healthcare Conference	GL
07/05/15	Receptos to Present at Bank of America Merrill Lynch 2015 Healthcare Conference	GL
29/04/15	Receptos to Hold First Quarter 2015 Results Conference Call	GL
23/04/15	Receptos : Active Equities to Watch in the Health Care Sector -- Cytori Therapeutics, Endo Intl., BioMarin Pharma, Novogen, and Receptos	PR
16/04/15	Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozanimod in Ulcerative Colitis	GL
01/04/15	Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple Sclerosis	GL
09/03/15	Receptos to Present at Barclays Global Healthcare Conference	GL
03/03/15	Receptos Provides Development Updates and Reports Fourth Quarter and Year End 2014 Financial Results	GL
26/02/15	Receptos to Hold Fourth Quarter and Year End 2014 Financial Results Conference Call	GL
18/02/15	Receptos Announces Oral Podium Presentation at Annual Meeting of European Crohn's and Colitis Organization (ECCO)	GL
09/02/15	Receptos to Present at Leerink Global Healthcare Conference	GL
22/12/14	Receptos Initiates SUNBEAM Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis	GL
24/11/14	Receptos Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Completion of Underwritten Public Offering of Common Stock	GL
29/10/14	Receptos to Hold Third Quarter 2014 Financial Results Conference Call and Webcast	GL
03/10/14	Receptos Announces First Patient Treated With Anti-Interleukin-13 Antibody in Phase 2 Trial for Eosinophilic Esophagitis	GL
12/08/14	Receptos Reports Second Quarter 2014 Financial Results	GL
08/08/14	Receptos to Present at Wedbush PacGrow Life Sciences Conference	GL
02/07/14	Receptos : Clinical Trial Update, Recommendations for Approval, Share Repurchase Programs, and Closing of Public Offering - Analyst Notes on Medtronic, Regeneron, Lilly, United Therapeutics and Receptos	PR